By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
The internal lens of the eye is emulsified with an ultrasonic handpiece and aspirated from the eye during phacoemulsification, a contemporary technique for performing cataract surgery. To keep the anterior chamber functioning, aspirated fluids are replenished by irrigation of a balanced salt solution.
Ocular surgery requires the right anesthetic. Most frequently, local anesthetics like lidocaine or tetracaine are injected into a treatment area to provide topical anesthesia.
As an alternative, to more completely immobilize the extraocular muscles and lessen pain perception, lidocaine and/or longer-acting bupivacaine anesthetic may be administered into the region around or beyond the eye muscle cone (peribulbar block) or behind the eye (retrobulbar block).
Sometimes, lid squeezing can be lessened by performing a facial nerve block with lidocaine and bupivacaine. Children, adults with cataracts from trauma to the eyes, severely frightened or reluctant patients, and animals should all be under general anesthesia. Cardiovascular monitoring is advised when receiving local anesthetic, and it is required when receiving general anesthesia.
The surgical site is cleaned and sterilized properly, and antiseptics like povidone-iodine are used to prevent infection. It is common to use sterile gloves, gowns, and drapes. The fluids are collected during phacoemulsification using a plastic sheet with a receptacle. To maintain open eyelids, an eye speculum is placed.
One or more incisions are created in the eye to allow the entrance of surgical tools prior to the phacoemulsification procedure.
The anterior face of the capsule containing the lens inside the eye is then removed by the surgeon. During phacoemulsification surgery, a device with microprocessor-controlled fluid dynamics is used. These can be built using a venturi or peristaltic kind of pump.
The Global Phacoemulsification Devices Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
In order to give surgeons more comfort and efficiency during cataract surgery, Johnson & Johnson (J&J) Vision has launched its phacoemulsification devices on a global scale.
Phacoemulsification, the form of cataract surgery that is most frequently used, enables doctors to emulsify and remove the internal lens of the eye when it develops cataracts and becomes hazy.
The method makes use of J&J’s WHITESTAR technology combined with elliptical tip movement for smoother cutting, even in thick or advanced cataracts. With less energy, lenses may be extracted more successfully because to this.
